Christopher Upton

Array ( [id] => 5791856 [patent_doc_number] => 20020162133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Transgenic mice containing mGluR8 metabotropic glutamate receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 09/900714 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19810 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20020162133.pdf [firstpage_image] =>[orig_patent_app_number] => 09900714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1206526 [patent_doc_number] => 06717032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-06 [patent_title] => 'Transgenic mice containing DEZ orphan receptor gene disruptions' [patent_app_type] => B2 [patent_app_number] => 09/900699 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19391 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/717/06717032.pdf [firstpage_image] =>[orig_patent_app_number] => 09900699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567500 [patent_doc_number] => 20020112255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Transgenic mice containing intestinal alkaline phosphatase gene disruptions' [patent_app_type] => new [patent_app_number] => 09/900708 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19737 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20020112255.pdf [firstpage_image] =>[orig_patent_app_number] => 09900708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600606 [patent_doc_number] => 20020042506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Ion exchange method for DNA purification' [patent_app_type] => new [patent_app_number] => 09/898473 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3685 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042506.pdf [firstpage_image] =>[orig_patent_app_number] => 09898473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245653 [patent_doc_number] => 20020046413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Transgenic mice containing BMP gene disruptions' [patent_app_type] => new [patent_app_number] => 09/897772 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19560 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20020046413.pdf [firstpage_image] =>[orig_patent_app_number] => 09897772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6283676 [patent_doc_number] => 20020108138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Transgenic mice containing RORgamma gene disruptions' [patent_app_type] => new [patent_app_number] => 09/895840 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20315 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20020108138.pdf [firstpage_image] =>[orig_patent_app_number] => 09895840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 528260 [patent_doc_number] => 07183405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Compositions and methods for labeling oligonucleotides' [patent_app_type] => utility [patent_app_number] => 09/894423 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 5575 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183405.pdf [firstpage_image] =>[orig_patent_app_number] => 09894423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 528260 [patent_doc_number] => 07183405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Compositions and methods for labeling oligonucleotides' [patent_app_type] => utility [patent_app_number] => 09/894423 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 5575 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183405.pdf [firstpage_image] =>[orig_patent_app_number] => 09894423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536835 [patent_doc_number] => 20020137134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Methods for producing modified glycoproteins' [patent_app_type] => new [patent_app_number] => 09/892591 [patent_app_country] => US [patent_app_date] => 2001-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13392 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137134.pdf [firstpage_image] =>[orig_patent_app_number] => 09892591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 532993 [patent_doc_number] => 07179901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Renal regulatory elements and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/311388 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 11373 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179901.pdf [firstpage_image] =>[orig_patent_app_number] => 10311388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157819 [patent_doc_number] => 20020146796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Mutated herpes simplex virus type 1 thymidine kinases and uses thereof' [patent_app_type] => new [patent_app_number] => 09/877381 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10757 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146796.pdf [firstpage_image] =>[orig_patent_app_number] => 09877381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016043 [patent_doc_number] => 20020102705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Regulatory sequences of the mouse villin gene - use in transgenesis' [patent_app_type] => new [patent_app_number] => 09/877935 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10168 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102705.pdf [firstpage_image] =>[orig_patent_app_number] => 09877935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828549 [patent_doc_number] => 20020068345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => '98P7C3: homeodomain protein highly expressed in various cancers' [patent_app_type] => new [patent_app_number] => 09/866359 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 54641 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068345.pdf [firstpage_image] =>[orig_patent_app_number] => 09866359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392595 [patent_doc_number] => 06533912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-18 [patent_title] => 'Increased throughput analysis of small compounds using multiple temporally spaced injections' [patent_app_type] => B2 [patent_app_number] => 09/859840 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 10386 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/533/06533912.pdf [firstpage_image] =>[orig_patent_app_number] => 09859840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5991142 [patent_doc_number] => 20020100068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Transgenic mouse for targeted recombination mediated by modified Cre-ER' [patent_app_type] => new [patent_app_number] => 09/853033 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20836 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20020100068.pdf [firstpage_image] =>[orig_patent_app_number] => 09853033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6129703 [patent_doc_number] => 20020076777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/852067 [patent_app_country] => US [patent_app_date] => 2001-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22135 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076777.pdf [firstpage_image] =>[orig_patent_app_number] => 09852067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6259799 [patent_doc_number] => 20020187474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Polymorphisms in the PNMT gene' [patent_app_type] => new [patent_app_number] => 09/845713 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23841 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187474.pdf [firstpage_image] =>[orig_patent_app_number] => 09845713 [rel_patent_id] =>[rel_patent_doc_number] =>)